世界の上咽頭がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nasopharyngeal Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4029 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、上咽頭がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線、化学療法）、用途別市場規模（病院、診療所、がん治療・リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・上咽頭がんの市場動向 ・企業の競争状況、市場シェア ・上咽頭がんの種類別市場規模（手術、放射線、化学療法） ・上咽頭がんの用途別市場規模（病院、診療所、がん治療・リハビリテーションセンター） ・上咽頭がんの北米市場規模2016-2027（アメリカ、カナダ） ・上咽頭がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・上咽頭がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・上咽頭がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・上咽頭がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Sanofi、Merck、Cyclacel Pharmaceuticals、Celgene、BioDiem） ・結論

Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.
Increasing geriatric population, rise in consumption of tobacco, increasing health awareness, changing lifestyle, are key driving factors for nasopharyngeal cancer treatment market.

Market Analysis and Insights: Global Nasopharyngeal Cancer Market
The global Nasopharyngeal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nasopharyngeal Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nasopharyngeal Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nasopharyngeal Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nasopharyngeal Cancer market.

Global Nasopharyngeal Cancer Scope and Market Size
Nasopharyngeal Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nasopharyngeal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Radiation
Chemotherapy

Segment by Application
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Sanofi
Merck
Cyclacel Pharmaceuticals
Celgene
BioDiem

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nasopharyngeal Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation
1.2.4 Chemotherapy
1.3 Market by Application
1.3.1 Global Nasopharyngeal Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nasopharyngeal Cancer Market Perspective (2016-2027)
2.2 Nasopharyngeal Cancer Growth Trends by Regions
2.2.1 Nasopharyngeal Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nasopharyngeal Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Nasopharyngeal Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Nasopharyngeal Cancer Industry Dynamic
2.3.1 Nasopharyngeal Cancer Market Trends
2.3.2 Nasopharyngeal Cancer Market Drivers
2.3.3 Nasopharyngeal Cancer Market Challenges
2.3.4 Nasopharyngeal Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nasopharyngeal Cancer Players by Revenue
3.1.1 Global Top Nasopharyngeal Cancer Players by Revenue (2016-2021)
3.1.2 Global Nasopharyngeal Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Nasopharyngeal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nasopharyngeal Cancer Revenue
3.4 Global Nasopharyngeal Cancer Market Concentration Ratio
3.4.1 Global Nasopharyngeal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nasopharyngeal Cancer Revenue in 2020
3.5 Nasopharyngeal Cancer Key Players Head office and Area Served
3.6 Key Players Nasopharyngeal Cancer Product Solution and Service
3.7 Date of Enter into Nasopharyngeal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nasopharyngeal Cancer Breakdown Data by Type
4.1 Global Nasopharyngeal Cancer Historic Market Size by Type (2016-2021)
4.2 Global Nasopharyngeal Cancer Forecasted Market Size by Type (2022-2027)

5 Nasopharyngeal Cancer Breakdown Data by Application
5.1 Global Nasopharyngeal Cancer Historic Market Size by Application (2016-2021)
5.2 Global Nasopharyngeal Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nasopharyngeal Cancer Market Size (2016-2027)
6.2 North America Nasopharyngeal Cancer Market Size by Type
6.2.1 North America Nasopharyngeal Cancer Market Size by Type (2016-2021)
6.2.2 North America Nasopharyngeal Cancer Market Size by Type (2022-2027)
6.2.3 North America Nasopharyngeal Cancer Market Size by Type (2016-2027)
6.3 North America Nasopharyngeal Cancer Market Size by Application
6.3.1 North America Nasopharyngeal Cancer Market Size by Application (2016-2021)
6.3.2 North America Nasopharyngeal Cancer Market Size by Application (2022-2027)
6.3.3 North America Nasopharyngeal Cancer Market Size by Application (2016-2027)
6.4 North America Nasopharyngeal Cancer Market Size by Country
6.4.1 North America Nasopharyngeal Cancer Market Size by Country (2016-2021)
6.4.2 North America Nasopharyngeal Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nasopharyngeal Cancer Market Size (2016-2027)
7.2 Europe Nasopharyngeal Cancer Market Size by Type
7.2.1 Europe Nasopharyngeal Cancer Market Size by Type (2016-2021)
7.2.2 Europe Nasopharyngeal Cancer Market Size by Type (2022-2027)
7.2.3 Europe Nasopharyngeal Cancer Market Size by Type (2016-2027)
7.3 Europe Nasopharyngeal Cancer Market Size by Application
7.3.1 Europe Nasopharyngeal Cancer Market Size by Application (2016-2021)
7.3.2 Europe Nasopharyngeal Cancer Market Size by Application (2022-2027)
7.3.3 Europe Nasopharyngeal Cancer Market Size by Application (2016-2027)
7.4 Europe Nasopharyngeal Cancer Market Size by Country
7.4.1 Europe Nasopharyngeal Cancer Market Size by Country (2016-2021)
7.4.2 Europe Nasopharyngeal Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nasopharyngeal Cancer Market Size (2016-2027)
8.2 Asia-Pacific Nasopharyngeal Cancer Market Size by Type
8.2.1 Asia-Pacific Nasopharyngeal Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nasopharyngeal Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nasopharyngeal Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Nasopharyngeal Cancer Market Size by Application
8.3.1 Asia-Pacific Nasopharyngeal Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nasopharyngeal Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nasopharyngeal Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Nasopharyngeal Cancer Market Size by Region
8.4.1 Asia-Pacific Nasopharyngeal Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nasopharyngeal Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nasopharyngeal Cancer Market Size (2016-2027)
9.2 Latin America Nasopharyngeal Cancer Market Size by Type
9.2.1 Latin America Nasopharyngeal Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Nasopharyngeal Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Nasopharyngeal Cancer Market Size by Type (2016-2027)
9.3 Latin America Nasopharyngeal Cancer Market Size by Application
9.3.1 Latin America Nasopharyngeal Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Nasopharyngeal Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Nasopharyngeal Cancer Market Size by Application (2016-2027)
9.4 Latin America Nasopharyngeal Cancer Market Size by Country
9.4.1 Latin America Nasopharyngeal Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Nasopharyngeal Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nasopharyngeal Cancer Market Size (2016-2027)
10.2 Middle East & Africa Nasopharyngeal Cancer Market Size by Type
10.2.1 Middle East & Africa Nasopharyngeal Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nasopharyngeal Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nasopharyngeal Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Nasopharyngeal Cancer Market Size by Application
10.3.1 Middle East & Africa Nasopharyngeal Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nasopharyngeal Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nasopharyngeal Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Nasopharyngeal Cancer Market Size by Country
10.4.1 Middle East & Africa Nasopharyngeal Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nasopharyngeal Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Nasopharyngeal Cancer Introduction
11.1.4 Roche Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Nasopharyngeal Cancer Introduction
11.2.4 Sanofi Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Nasopharyngeal Cancer Introduction
11.3.4 Merck Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Cyclacel Pharmaceuticals
11.4.1 Cyclacel Pharmaceuticals Company Details
11.4.2 Cyclacel Pharmaceuticals Business Overview
11.4.3 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Introduction
11.4.4 Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.4.5 Cyclacel Pharmaceuticals Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Nasopharyngeal Cancer Introduction
11.5.4 Celgene Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 BioDiem
11.6.1 BioDiem Company Details
11.6.2 BioDiem Business Overview
11.6.3 BioDiem Nasopharyngeal Cancer Introduction
11.6.4 BioDiem Revenue in Nasopharyngeal Cancer Business (2016-2021)
11.6.5 BioDiem Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nasopharyngeal Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation
Table 4. Key Players of Chemotherapy
Table 5. Global Nasopharyngeal Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nasopharyngeal Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nasopharyngeal Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Nasopharyngeal Cancer Market Share by Regions (2016-2021)
Table 9. Global Nasopharyngeal Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Nasopharyngeal Cancer Market Share by Regions (2022-2027)
Table 11. Nasopharyngeal Cancer Market Trends
Table 12. Nasopharyngeal Cancer Market Drivers
Table 13. Nasopharyngeal Cancer Market Challenges
Table 14. Nasopharyngeal Cancer Market Restraints
Table 15. Global Nasopharyngeal Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Nasopharyngeal Cancer Market Share by Players (2016-2021)
Table 17. Global Top Nasopharyngeal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer as of 2020)
Table 18. Ranking of Global Top Nasopharyngeal Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Nasopharyngeal Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nasopharyngeal Cancer Product Solution and Service
Table 22. Date of Enter into Nasopharyngeal Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Nasopharyngeal Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Nasopharyngeal Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Nasopharyngeal Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Nasopharyngeal Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Nasopharyngeal Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Nasopharyngeal Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Nasopharyngeal Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Nasopharyngeal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Nasopharyngeal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Nasopharyngeal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Nasopharyngeal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Nasopharyngeal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Nasopharyngeal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Nasopharyngeal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Nasopharyngeal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Nasopharyngeal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Nasopharyngeal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Nasopharyngeal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nasopharyngeal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nasopharyngeal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nasopharyngeal Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Nasopharyngeal Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Nasopharyngeal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Nasopharyngeal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Nasopharyngeal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Nasopharyngeal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Nasopharyngeal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Nasopharyngeal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Nasopharyngeal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nasopharyngeal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nasopharyngeal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nasopharyngeal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Nasopharyngeal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Nasopharyngeal Cancer Product
Table 65. Roche Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Nasopharyngeal Cancer Product
Table 70. Sanofi Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Nasopharyngeal Cancer Product
Table 75. Merck Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Cyclacel Pharmaceuticals Company Details
Table 78. Cyclacel Pharmaceuticals Business Overview
Table 79. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product
Table 80. Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 81. Cyclacel Pharmaceuticals Recent Development
Table 82. Celgene Company Details
Table 83. Celgene Business Overview
Table 84. Celgene Nasopharyngeal Cancer Product
Table 85. Celgene Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 86. Celgene Recent Development
Table 87. BioDiem Company Details
Table 88. BioDiem Business Overview
Table 89. BioDiem Nasopharyngeal Cancer Product
Table 90. BioDiem Revenue in Nasopharyngeal Cancer Business (2016-2021) & (US$ Million)
Table 91. BioDiem Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nasopharyngeal Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiation Features
Figure 4. Chemotherapy Features
Figure 5. Global Nasopharyngeal Cancer Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 9. Nasopharyngeal Cancer Report Years Considered
Figure 10. Global Nasopharyngeal Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Nasopharyngeal Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nasopharyngeal Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Nasopharyngeal Cancer Market Share by Regions (2022-2027)
Figure 14. Global Nasopharyngeal Cancer Market Share by Players in 2020
Figure 15. Global Top Nasopharyngeal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Nasopharyngeal Cancer Revenue in 2020
Figure 17. Global Nasopharyngeal Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Nasopharyngeal Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Nasopharyngeal Cancer Market Share by Type (2016-2027)
Figure 21. North America Nasopharyngeal Cancer Market Share by Application (2016-2027)
Figure 22. North America Nasopharyngeal Cancer Market Share by Country (2016-2027)
Figure 23. United States Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nasopharyngeal Cancer Market Share by Type (2016-2027)
Figure 27. Europe Nasopharyngeal Cancer Market Share by Application (2016-2027)
Figure 28. Europe Nasopharyngeal Cancer Market Share by Country (2016-2027)
Figure 29. Germany Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nasopharyngeal Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Nasopharyngeal Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Nasopharyngeal Cancer Market Share by Region (2016-2027)
Figure 39. China Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nasopharyngeal Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Nasopharyngeal Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Nasopharyngeal Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nasopharyngeal Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Nasopharyngeal Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Nasopharyngeal Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Nasopharyngeal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 61. Cyclacel Pharmaceuticals Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 62. Celgene Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 63. BioDiem Revenue Growth Rate in Nasopharyngeal Cancer Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---